{
  "ptid_time": "037_S_5162_2013-05-03",
  "img_path": "/data/qiuhui/data/adni/images/037_S_5162/2013-05-03/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 26,036 mm³, 13.3% below the reference mean. With a Z-score of -0.32 (37.6th percentile), this represents normal volume ; hippocampal volume measures 6,813 mm³, 15.1% below the reference mean. With a Z-score of -1.51 (6.5th percentile), this represents moderate atrophy; whole brain volume measures 994,065 mm³, 12.4% below the reference mean. With a Z-score of -1.75 (4.0th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,587 mm³, 15.9% below the reference mean. With a Z-score of -1.10 (13.6th percentile), this represents mild atrophy; fusiform gyrus volume measures 17,314 mm³, 13.0% below the reference mean. With a Z-score of -1.08 (13.9th percentile), this represents mild atrophy; middle temporal gyrus volume measures 17,706 mm³, 21.0% below the reference mean. With a Z-score of -1.73 (4.2th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 69.3 years. Gender is Male. Education: 18 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Smoking; Major Surgical Procedures. MMSE: 24.0. MoCA: 13.0. Logical Memory: 4.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.86 SUVR (moderate reduced); Amyloid beta: 1416.00 pg/mL (mild elevated); Total tau: 250.10 pg/mL (normal ); Phosphorylated tau: 19.52 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate atrophy in the hippocampus and middle temporal gyrus, along with mild atrophy in the entorhinal cortex and fusiform gyrus—key regions affected in Alzheimer’s disease (AD). The MMSE (24) and MoCA (13) scores indicate cognitive impairment, while biomarker findings (mildly elevated Aβ, reduced AV45) suggest amyloid pathology but no significant tauopathy. The absence of APOE4 reduces genetic risk but does not rule out AD.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to underlying Alzheimer’s pathology).  \n\n**Confidence:** **Medium** (cognitive scores and hippocampal atrophy strongly suggest MCI, but biomarker discordance—elevated Aβ without elevated tau—warrants caution).  \n\n*Note:* Progression to dementia is probable given the hippocampal atrophy and amyloid burden, but current cognitive deficits do not yet meet dementia criteria. Follow-up for functional decline is recommended.",
  "timestamp": "2025-07-26T06:50:06.763167"
}